Research Working Group      Policy Development Working Group      International Affairs Working Group

Linking Researchers and Industry

  • The Avicenna Alliance is dedicated to ensuring the full innovation cycle of predictive medicine is represented.
  • The Virtual Physiological Human (VPH) Initiative, carries a non-diminishable 50% board representation on the Avicenna Alliance with Industry representatives from Medical Devices, Pharmaceuticals and Software also maintaining a 50% board membership.
  • The VPH Institute is a massive network of Research Organisations and Universities engaged in predictive or in silico medicine.
  • The VPH institute has its origins in a European Commission endorsed research area on computer modeling and simulation and has been active for over 10 years.
  • This partnership of industry and researchers allows the Avicenna Alliance to address challenges to the predictive or in silico market from pre-clinical research all the way to post-market. 

Avicenna Alliance news

The Commission launched a new call for advanced health approaches to rapidly respond to COVID-19

On 19 May the European Commission launched a new call for an Expression of Interest with a budget of...

find out more ›

Members of the European Parliament call for supporting health policies and health systems in the next Multiannual Financial Framework

On 1 May Members of the European Parliament (MEPs) sent a letter...

find out more ›

Launch of the European COVID-19 Data Platform

On 20 April the Commission together with EU Member States and several partners, including EMBL’s European Bioinformatics Institute (EMBL-EBI) and...

find out more ›

Show all activites

Sign up for our monthly newsletter!


Sign up